Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATEX | Common Stock | Award | $0 | +3.9K | $0.00 | 3.9K | Jan 2, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATEX | Stock Option (Right to Buy) | Award | $0 | +59K | $0.00 | 59K | Jan 2, 2024 | Common Stock | 59K | $33.62 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | The restricted stock vests in full on August 7, 2024. |
F2 | Options awarded in connection with director's appointment to the Board as Vice Chairman. For further information see the Anterix Inc. Form 8-K filed with the Securities Exchange Commission on January 4, 2024. |
F3 | 1/3rd of the option shares vest and become exercisable on January 2, 2025, with the remaining option shares vesting in 2 equal annual installments thereafter. |